Iberia Pharmaceuticals has officially announced the launch of a new manufacturing and research facility in Jhajjar, Haryana. Covering 60,000 sq. ft., the company expects the facility to begin operations by mid-2026, investing ₹70 crore into the project. This initiative aligns with the Government of India’s ‘Make in India’ programme and demonstrates Iberia’s commitment to producing high-quality healthcare products domestically. Focus ...